Riskpilot← Back to searchSign inGet full accessMedbase Oy
OYActiveY-tunnus 2398201-9Yliopistonkatu 15-B16Other business support service activities n.e.c. · NACE 8299Est. 2011— employees
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
4.7%
Financial strength
Net profit 2024
EUR 0
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | — |
| Total assets | EUR 1,4M | +7% |
| Equity | EUR 67K | +34% |
| Employees | — | — |
Legal name
Medbase Oy
Y-tunnus number
2398201-9
Legal form
Osakeyhtiö
NACE code
8299 · Other business support service activities n.e.c.
Founded
18. maaliskuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveydenhuollon tietokantojen myynti ja markkinointi. Yhtiö voi myös omistaa ja hallita kiinteistöjä, asunto-osakeyhtiöiden osakkeita ja arvopapereita ja harjoittaa sijoitustoimintaa.
Address
Yliopistonkatu 15-B16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 430 | 3 639 | 3 830 | 3 888 | 0 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | 1 536 | 1 744 | 3 | 8 | 0 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 1 536 | 1 744 | 3 | 8 | 0 |
| Net financials | 6 | 5 | −1 | 2 | 0 |
| Profit before tax | 311 | 353 | 1 | 0 | 0 |
| Tax | 309 | 350 | 1 | −0 | −0 |
| Net profit | 2 | 3 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 718 | 720 | 1 709 | 1 339 | 1 430 |
| Equity | 13 | 15 | 71 | 50 | 67 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 705 | 705 | 1 638 | 1 289 | 1 363 |
| Total debt | 705 | 705 | 1 638 | 1 289 | 1 363 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
4.7%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
20.25×
This company
0.62×
Market median
-3166% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KP Deputy Member | Deputy Member | 2022 |
| Former (4) | ||
HT Deputy auditor | Deputy auditor | 2011 – 2022 |
JO Deputy Member | Deputy Member | 2011 – 2022 |
PV | Audit | 2011 – 2022 |
JV | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairperson | 2022 | |
| Former (1) | ||
| Board of Directors | 2011 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holdbase Oy
Medbase Oy Board members of Medbase Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helena Tuula Mikkonen | Deputy auditor | 0 companies |
| Jori Osmo Joeli Ruuskanen | Deputy Member | 0 companies |
| Pekka Veli-Martti Haavisto | Audit | 0 companies |
| Juha Veikko Aulis Hilmola | Audit | 0 companies |
| Kari Petri Laine | Deputy Member | 0 companies |
| Tuomas Olavi Korhonen | Board of Directors | 0 companies |
| Simo Kalevi Pietilä | Board of Directors | 0 companies |
| Atte Kristian Auranen | Chairperson | 0 companies |